Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction.
Zeng J, Ma X, Zhao Z, Chen Y, Wang J, Hao Y, Yu J, Zeng Z, Chen N, Zhao M, Tang J, Gong D.
Zeng J, et al. Among authors: zhao z, zhao m.
Front Pharmacol. 2021 Sep 14;12:682713. doi: 10.3389/fphar.2021.682713. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34594214
Free PMC article.